FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Griffin William L. Jr   2. Issuer Name and Ticker or Trading Symbol WRIGHT MEDICAL GROUP INC [WMGI] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) SVP GM BioMimetic Therapeutics (Last) (First) (Middle) 1023 CHERRY ROAD 3. Date of Earliest Transaction (Month/Day/Year) 10/01/2015 (Street) MEMPHIS, TN 38117 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 10/01/2015   D   68,995 D (1) 0 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Underlying Securities (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$ 29.88	10/01/2015		D			100,000	(2)	07/22/2018	Common Stock	100,000	(3)	0	D
Employee Stock Option (Right to Buy)	$ 15.47	10/01/2015		D			11,811	(2)	05/13/2019	Common Stock	11,811	(4)	0	D
Employee Stock Option (Right to Buy)	$ 18.37	10/01/2015		D			9,886	(2)	05/13/2020	Common Stock	9,886	(5)	0	D
Employee Stock Option (Right to Buy)	$ 15.5	10/01/2015		D			12,855	(2)	05/11/2021	Common Stock	12,855	(6)	0	D
Employee Stock Option (Right to Buy)	$ 18.24	10/01/2015		D			1,975	(2)	04/16/2022	Common Stock	1,975	(7)	0	D
Employee Stock Option (Right to Buy)	$ 21.39	10/01/2015		D			20,067	(2)	05/09/2022	Common Stock	20,067	(8)	0	D
Employee Stock Option (Right to Buy)	$ 24.66	10/01/2015		D			19,948	(2)	05/14/2023	Common Stock	19,948	(9)	0	D
Employee Stock Option (Right to Buy)	$ 29.95	10/01/2015		D			17,594	(2)	05/13/2024	Common Stock	17,594	(10)	0	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Griffin William L. Jr 1023 CHERRY ROAD MEMPHIS, TN 38117			SVP GM BioMimetic Therapeutics

Signatures

/s/ Marija S. Nelson, Attorney-in-fact		10/05/2015
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, Tornier N.V., Trooper Holdings Inc., and Trooper Merger Sub Inc., which became effective on October 1, 2015, in exchange for 71,126 Wright Medical Group N.V. ("Wright N.V.") ordinary shares having a market value of $20.39 per share at the effective time of the merger.
(2)	The employee stock option vests in equal annual installments over a period of four years after the grant date.
(3)	This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 103,090 Wright N.V. at a price of $28.99 per share.
(4)	This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 12,175 Wright N.V. at a price of $15.01 per share.
(5)	This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 10,191 Wright N.V. at a price of $17.82 per share.
(6)	This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 13,252 Wright N.V. at a price of $15.04 per share.
(7)	This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 2,036 Wright N.V. at a price of $17.70 per share.
(8)	This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 20,687 Wright N.V. at a price of $20.75 per share.
(9)	This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 20,564 Wright N.V. at a price of $23.93 per share.
(10)	This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 18,137 Wright N.V. at a price of $29.06 per share.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.